ARCH Venture Fund XII, L.P. - 30 Mar 2026 SCHEDULE 13D/A Report for Neumora Therapeutics, Inc. Common Stock, $0.0001 par value (NMRA)

Filing Manager
ARCH Venture Fund XII, L.P.
Reporting Manager
Kristina Burow
Security
Neumora Therapeutics, Inc. Common Stock, $0.0001 par value
Symbol
NMRA
Shares outstanding
181,633,257 shares
Disclosed Ownership
33,965,419 shares
Ownership
19%
Form type
SCHEDULE 13D/A
Filing time
01 Apr 2026, 16:10:03 UTC
Date of event
30 Mar 2026
Previous filing
29 Oct 2025
SEC
View on sec.gov

Sponsored

Quoteable Key Fact

"ARCH Venture Fund XII, L.P. disclosed 19% ownership in Neumora Therapeutics, Inc. Common Stock, $0.0001 par value (NMRA) on 30 Mar 2026."

Quick Takeaways

  • ARCH Venture Fund XII, L.P. filed SCHEDULE 13D/A for Neumora Therapeutics, Inc. Common Stock, $0.0001 par value (NMRA).
  • Disclosed ownership: 19%.
  • Date of event: 30 Mar 2026.

What Changed

  • Previous schedule filing date: 29 Oct 2025.
  • Current filing was accepted on 01 Apr 2026, 16:10.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Official SEC Source

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (18)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
ARCH Venture Fund VII, L.P. 19% 33,847,838 0 33,847,838 ARCH Venture Partners VII, L.P. its General Partner 0001402439
ARCH Venture Fund VIII Overage, L.P. 19% 33,847,838 0 33,847,838 ARCH Venture Partners VIII, LLC its General Partner 0001617237
ARCH Venture Fund X, L.P. 19% 33,847,838 0 33,847,838 ARCH Venture Partners X, L.P. its General Partner 0001757011
ARCH Venture Fund X Overage, L.P. 19% 33,847,838 0 33,847,838 ARCH Venture Partners X Overage, L.P. its General Partner 0001757017
ARCH Venture Fund XII, L.P. 19% 33,847,838 0 33,847,838 ARCH Venture Partners XII, L.P. its General Partner 0001906837
ARCH Venture Partners VII, L.P. 19% 33,847,838 0 33,847,838 ARCH Venture Partners VII, LLC its General Partner 0001544444
ARCH Venture Partners X, L.P. 19% 33,847,838 0 33,847,838 ARCH Venture Partners X, LLC its General Partner 0001782583
ARCH Venture Partners X Overage, L.P. 19% 33,847,838 0 33,847,838 ARCH Venture Partners X, LLC its General Partner 0001768905
ARCH Venture Partners XII, L.P. 19% 33,847,838 0 33,847,838 ARCH Venture Partners XII, LLC its General Partner 0001979765
ARCH Venture Partners VII, LLC 19% 33,847,838 0 33,847,838 /s/ Mark McDonnell* Mark McDonnell, as Attorney-in-Fact for Keith Crandell, Managing Director 0001544443
ARCH Venture Partners VIII, LLC 19% 33,847,838 0 33,847,838 /s/ Mark McDonnell* Mark McDonnell, as Attorney-in-Fact for Keith Crandell, Managing Director 0001616165
ARCH Venture Partners X, LLC 19% 33,847,838 0 33,847,838 /s/ Mark McDonnell* Mark McDonnell, as Attorney-in-Fact for Robert Nelsen, Managing Director 0001769012
ARCH Venture Partners XII, LLC 19% 33,847,838 0 33,847,838 /s/ Mark McDonnell* Mark McDonnell, as Attorney-in-Fact for Keith Crandell, Managing Director 0001979548
Robert Nelsen 19% 33,847,838 0 33,847,838 /s/ Mark McDonnell* Mark McDonnell, as Attorney-in-Fact for Robert Nelsen 0001219042
Keith Crandell 19% 33,847,838 0 33,847,838 /s/ Mark McDonnell* Mark McDonnell, as Attorney-in-Fact for Keith Crandell 0001219039
Clinton Bybee 2% 3,708,794 0 3,708,794 /s/ Mark McDonnell* Mark McDonnell, as Attorney-in-Fact for Clinton Bybee 0001219043
Kristina Burow 19% 33,965,419 117,581 33,847,838 /s/ Mark McDonnell* Mark McDonnell, as Attorney-in-Fact for Kristina Burow 0001569248
Steven Gillis 17% 31,526,272 0 31,526,272 /s/ Mark McDonnell* Mark McDonnell, as Attorney-in-Fact for Steven Gillis 0001229592

Sponsored